SCHEMBL474710

SCHEMBL474710

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.O=S(=O)(F)F

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.52
CA1 P00915 9/20 0.48
MMP1 P03956 4/20 0.48
MMP2 P08253 4/20 0.48
MMP9 P14780 4/20 0.48
MMP8 P22894 4/20 0.48
MMP13 P45452 4/20 0.48
LMNA P02545 1/20 0.44
THRB P10828 1/20 0.43
F2 P00734 4/20 0.42
PRSS1 P07477 4/20 0.42
PRSS2 P07478 4/20 0.42
PRSS3 P35030 4/20 0.42
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perflexane SCHEMBL3192336 1.00 CA2 (0.52) CA2CA1MMP1MMP2MMP9
Perflenapent SCHEMBL14763328 1.00 CA2 (0.52) CA2CA1MMP1MMP2MMP9
SCHEMBL9505503 1.00 CA2 (0.52) CA2CA1MMP1MMP2MMP9
Perflubutane SCHEMBL73685 0.96 CA2 (0.48) CA2CA1MMP1MMP2MMP9
Perflutren SCHEMBL1470237 0.88 CA2 (0.41) CA2CA1MMP1MMP2MMP9
SCHEMBL11563004 0.86 TSHR (0.53) CA2CA1MMP1MMP2MMP9
Sulfuric Acid SCHEMBL2819379 0.81 CA2 (0.52) CA2CA1MMP1MMP2MMP9
Perflubutane SCHEMBL6557063 0.81 TSHR (0.57) CA2CA1MMP1MMP2MMP9
SCHEMBL2135581 0.81 CA2 (0.50) CA2CA1MMP1MMP2MMP9
SCHEMBL3685588 0.81 CA2 (0.50) CA2CA1MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008706-A1 Utilization of Micro Hydroflocs for the Effective and Complete Removal of Long and Short Chain PFAS Molecules from Contaminated Water StreamGo Water USA LLC (US) 2026-01-08 US claimed
EP-4628454-A1 REMOVAL OF DIOXANE AND OTHER RECALCITRANT CONTAMINANTS FROM WATER USING NANOBUBBLES IN ADVANCED OXIDATION PROCESSES StreamGo Water USA LLC (US) 2025-10-08 EP claimed
US-20250304478-A1 Removal of Dioxane and other Contaminants from Water using Oxygen Nanobubbles in Advanced Oxidation Processes StreamGo Water USA LLC (US) 2025-10-02 US claimed
US-12290835-B2 Methods for stabilization of self-assembled monolayers (SAMs) using sequentially pulsed initiated chemical vapor deposition (spiCVD) TOKYO ELECTRON LIMITED (JP) 2025-05-06 US claimed
WO-2024019841-A1 METHODS FOR STABILIZATION OF SELF-ASSEMBLED MONOLAYERS (SAMS) USING SEQUENTIALLY PULSED INITIATED CHEMICAL VAPOR DEPOSITION (SPICVD) TOKYO ELECTRON LIMITED (JP) 2024-01-25 WO claimed
US-20240017290-A1 Methods For Stabilization Of Self-Assembled Monolayers (SAMs) Using Sequentially Pulsed Initiated Chemical Vapor Deposition (spiCVD) TOKYO ELECTRON LIMITED (JP) 2024-01-18 US claimed
US-10794853-B2 Methods for depositing polymer layer for sensor applications via hot wire chemical vapor deposition APPLIED MATERIALS, INC. (US) 2020-10-06 US claimed
EP-3551780-A1 METHODS FOR DEPOSITING POLYMER LAYER FOR SENSOR APPLICATIONS VIA HOT WIRE CHEMICAL VAPOR DEPOSITION Applied Materials, Inc. (US) 2019-10-16 EP claimed
US-20180164245-A1 METHODS FOR DEPOSITING POLYMER LAYER FOR SENSOR APPLICATIONS VIA HOT WIRE CHEMICAL VAPOR DEPOSITION APPLIED MATERIALS, INC. 2018-06-14 US claimed
US-9957172-B2 Method for removing perfluorinated compounds by concentration and separation BEIJING NORMAL UNIVERSITY (CN) 2018-05-01 US claimed
WO-2011028434-A2 3D APPROACH ON BATTERY AND SUPERCAPACITOR FABRICATION BY INITIATION CHEMICAL VAPOR DEPOSITION TECHNIQUES APPLIED MATERIALS, INC. (US) 2011-03-10 WO claimed
US-20110045349-A1 3D APPROACH ON BATTERY AND SUPERCAPACITOR FABRICATION BY INITIATION CHEMICAL VAPOR DEPOSITION TECHNIQUES APPLIED MATERIALS, INC. (US) 2011-02-24 US claimed
EP-1015664-B1 ELECTROCHEMICAL FLUORINATION USING INTERRUPTED CURRENT MINNESOTA MINING & MFG (US) 2007-09-26 EP claimed
EP-1448807-A4 FLUOROCARBON-ORGANOSILICON COPOLYMERS AND COATINGS PREPARED BY HOT-FILAMENT CHEMICAL VAPOR DEPOSITION MASSACHUSETTS INST TECHNOLOGY (US) 2005-07-13 EP claimed
US-6887578-B2 Fluorocarbon-organosilicon copolymers and coatings prepared by hot-filament chemical vapor deposition MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-05-03 US claimed
EP-1448807-A1 FLUOROCARBON-ORGANOSILICON COPOLYMERS AND COATINGS PREPARED BY HOT-FILAMENT CHEMICAL VAPOR DEPOSITION MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-08-25 EP claimed
US-20030138645-A1 Fluorocarbon- organosilicon copolymers and coatings prepared by hot-filament chemical vapor deposition NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-07-24 US claimed
WO-2003038143-A1 FLUOROCARBON-ORGANOSILICON COPOLYMERS AND COATINGS PREPARED BY HOT-FILAMENT CHEMICAL VAPOR DEPOSITION MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-05-08 WO claimed
US-20010017268-A1 Electrochemical fluorination using interrupted current 3M INNOVATIVE PROPERTIES COMPANY 2001-08-30 US claimed
US-6267865-B1 USING ELECTROLYTIC CELL 3M INNOVATIVE PROPERTIES COMPANY 2001-07-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008706-A1 Utilization of Micro Hydroflocs for the Effective and Complete Removal of Long and Short Chain PFAS Molecules from Contaminated Water PFAS, FGB, F8 CA2 1892/4885CA1 2357/4885MMP1 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.